About the Event

MTPConnect is delivering the $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease, supported by the MRFF. The TTRA is providing a new integrated research program to improve the prevention, diagnosis, treatment and management of diabetes and cardiovascular disease (D&CVD) in Australia.

The TTRA is now calling for Expressions of Interest (EOI) via the second round of the Research Projects opportunity, to fund eligible organisations in developing innovative digital health solutions, medical devices, therapeutics and behavioural interventions for D&CVD.

TTRA Research Projects will be funded for between $200,000 - $750,000, for a maximum of 24 months and applicants will be required to provide a co-contribution (cash or in-kind) to the value of 50% of the TTRA funding request to be eligible.

Guidelines & application information can be found on the TTRA webpage at www.mtpconnect.org.au. Submissions close at 16:00 AEDT on Thursday 4 November 2021.

Hear from MTPConnect's:
• Managing Director & CEO - Dr Dan Grant
• Senior Director TTRA Program - Lauren Kelly
• Director TTRA Program - Dr Mana Liao
• Project Manager TTRA Program - Dr Erin McAllum

You'll also hear from the TTRA Partners:
• ANDHealth's Chief Product Officer & Co-Founder - Grace Lethlean
• MDPP's National Program Manager - Olivia White
• UniQuest's Project Manager, TTRA Program - Dr Leigh Ford

Register for the TTRA Research Projects Information Session today to find out more about the funding application process.

NOTE: For helpful tips on preparing your application head to www.mtpconnect.org.au/webinars to view our on-demand webinar 'Show Me The Money: Preparing Successful Commercialisation Funding Applications (18 Nov 2020)'.

AUDIENCE: Diabetes and cardiovascular researchers, research institutes, universities, SMEs, industry, clinicians, digital health, medical device, therapeutics, behavioural interventions

DURATION: 1hr 15mins
....